Regulation FD Disclosure Form 8 K

Item 7.01 Regulation FD Disclosure

NeuroPace, Inc. ("NeuroPace") is scheduled to present at the 43^rd Annual J.P. Morgan Healthcare Conference on January 15, 2025, at approximately 4:30 p.m. Pacific time (7:30 p.m. Eastern time), and the presentation will be available through a live audio webcast. The presentation materials will be available on the Events section of the NeuroPace investor site at https://investors.neuropace.com/news-and-events/events,along with instructions for accessing the webcast.

The foregoing information in this Item 7.01 is being furnished and shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, except as shall be expressly set forth by specific reference in such filing.